IMPACT FACTOR JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOGS LaTeX 5G Tutorial
 




Letters in Drug Design and Discovery - Impact Factor, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and other Important Metrics


Impact Factor

0.93

H-Index

28

Rank

17546

SJR

0.207

Note: The impact factor shown here is equivalent to citescore and is, therefore, used as a replacement for the same. Citescore is produced by Scopus, and can be a little higher or different compared to the impact factor produced by Journal Citation Report. Please refer to Web of Science data source for checking the exact journal impact factor ™ (Thomson Reuters) metric.

Title Letters in Drug Design and Discovery
Publication Type journal
Subject Area, Categories, Scope Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)
h-index 28
Overall Rank/Ranking 17546
SCImago Journal Rank (SJR) 0.207
Impact Factor 0.93
Publisher Bentham Science Publishers
Country United Arab Emirates
ISSN 15701808



About Letters in Drug Design and Discovery


Letters in Drug Design and Discovery is a journal covering the technologies/fields/categories related to Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4). It is published by Bentham Science Publishers. The overall rank of Letters in Drug Design and Discovery is 17546. According to SCImago Journal Rank (SJR), this journal is ranked 0.207. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 28. The best quartile for this journal is Q3.

The ISSN of Letters in Drug Design and Discovery journal is 15701808. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Letters in Drug Design and Discovery is cited by a total of 330 articles during the last 3 years (Preceding 2018).

Letters in Drug Design and Discovery Impact Factor 2018-2019


The impact factor (IF) 2018 of Letters in Drug Design and Discovery is 0.93, which is computed in 2019 as per it's definition. Letters in Drug Design and Discovery IF is increased by a factor of 0.05 and approximate percentage change is 5.68% when compared to preceding year 2017, which shows a rising trend. The impact factor (IF), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal.



Table Setting

Letters in Drug Design and Discovery Impact Factor 2019 Prediction


IF 2018 of Letters in Drug Design and Discovery is 0.93. If the same upward trend persists, impact factor of joule may rise in 2019 as well.

Letters in Drug Design and Discovery h-index


  Table Setting

Letters in Drug Design and Discovery has an h-index of 28. It means 28 articles of this journal have more than 28 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.

Letters in Drug Design and Discovery ISSN


The ISSN of Letters in Drug Design and Discovery is 15701808. ISSN stands for International Standard Serial Number. An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Letters in Drug Design and Discovery Rank and SCImago Journal Rank (SJR)


The overall rank of Letters in Drug Design and Discovery is 17546. According to SCImago Journal Rank (SJR), this journal is ranked 0.207. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

Letters in Drug Design and Discovery Publisher


Table Setting

Letters in Drug Design and Discovery is published by Bentham Science Publishers. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2005-ongoing. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.

How to publish in Letters in Drug Design and Discovery


If your research field is/are related to Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4), then you can visit the official website of the journal.

Acceptance Rate


To check the acceptance rate of this journal, visit here.

Call for Paper, Submission Guidelines, Notification Date, and Submission Deadline 2020/2019


Visit the official website of the journal/conference for the call for paper, submission guidelines, notification date, and submission deadlines.


Source: https://www.scimagojr.com/journalrank.php



Impact Factor, h-Index, and other important details of other Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Factor
Journal of Educational Media and Library Science journal 24329 Tamkang University 7 0.44
Journal of Drug Delivery Science and Technology journal 8297 Editions de Sante 38 2.69
Infocommunications Journal journal 23774 Scientific Association for Infocommunications 6 0.48
Biological Invasions journal 3027 Kluwer Academic Publishers 97 2.93
Journal of Imagery Research in Sport and Physical Activity journal 13847 Walter de Gruyter GmbH 8 0.63
Cave and Karst Science journal 22423 British Cave Research Association 14 0.14
Osterreichische Zeitschrift fur Politikwissenschaft journal 22049 Docker Verlag 6 0.10
AllThingsCellular 2015 - Proceedings of the 5th Workshop on All Things Cellular: Operations, Applications and Challenges, Part of SIGCOMM 2015 conference and proceedings 6954 6 0.00
Surgery journal 2192 Mosby Inc. 148 3.18
European Journal for Philosophy of Science journal 10248 Springer Verlag 15 0.86

Check complete list

Year wise Impact Factor (IF) of Letters in Drug Design and Discovery

Year Impact Factor (IF)
2019Coming Soon
20180.93
20170.88
20161.24
20151.07
20140.85



Top Journals/Conferences in Pharmaceutical Science

Nano Today
Elsevier BV | Netherlands

Advanced Drug Delivery Reviews
Elsevier BV | Netherlands

International Journal of Pharmaceutical Investigation
Wolters Kluwer Medknow Publications | India

Journal of Controlled Release
Elsevier BV | Netherlands

Advanced healthcare materials
John Wiley and Sons Ltd | United Kingdom

Nanotechnology, Science and Applications
Dove Medical Press Ltd. | New Zealand

Bioconjugate Chemistry
American Chemical Society | United States

Nanomedicine: Nanotechnology, Biology, and Medicine
Elsevier BV | Netherlands

Molecular Pharmaceutics
American Chemical Society | United States

Expert Opinion on Drug Delivery
Taylor & Francis | United Kingdom


Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy
Cell Press | United States

Cell Chemical Biology
Elsevier Inc. | United States

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Current Opinion in Pharmacology
Elsevier BV | Netherlands

Journal of Medicinal Chemistry
American Chemical Society | United States

Protein & Cell
Springer Verlag | Germany

Drug Discovery Today
Elsevier BV | Netherlands

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland


Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central | United Kingdom

EMBO Molecular Medicine
John Wiley & Sons Ltd. | United Kingdom

Trends in Molecular Medicine
Elsevier BV | Netherlands

Journal for ImmunoTherapy of Cancer
BioMed Central | United Kingdom

Molecular Therapy
Cell Press | United States

Molecular Cancer
BioMed Central | United Kingdom

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom